Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 6, 2026

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

Molecular characterization of interdigitating dendritic cell sarcoma.

Glen J Weiss1, Arlet Alarcon, Maqbool Halepota

  • 1Virginia G. Piper Cancer Center at Scottsdale Healthcare, Scottsdale, USA.

Rare Tumors
|December 9, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TWEAK/FN14 inhibition synergizes with oncogene-directed tyrosine kinase inhibitors to overcome resistance across multiple driver contexts.

Scientific reports·2026
Same author

Reply to "Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer".

Cancer·2026
Same author

A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM), and paricalcitol as neoadjuvant therapy in pancreatic cancer.

The oncologist·2026
Same author

Discovery of Structurally Distinct Covalent KRAS G12C Inhibitor Scaffolds Through Large-Scale In Silico Screening and Experimental Validation.

Cancers·2026
Same author

Structure-guided identification and biological evaluation of reversible EGFR C797S inhibitors.

Scientific reports·2026
Same author

A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer.

Cancer·2026

Interdigitating dendritic cell sarcoma is a rare cancer with no standard treatment. This case study details a patient who achieved disease-free survival after surgical resection, with tumor targets identified for potential future therapies.

Area of Science:

  • Oncology
  • Surgical Pathology

Background:

  • Interdigitating dendritic cell sarcoma (IDCS) is an exceptionally rare neoplasm.
  • There is a lack of established treatment protocols for IDCS, necessitating novel therapeutic strategies.

Observation:

  • A patient diagnosed with interdigitating dendritic cell sarcoma underwent surgical resection.
  • The patient has remained disease-free following the surgical intervention.

Findings:

  • Immunohistochemical staining was performed on the resected tumor.
  • This analysis identified potential druggable targets within the tumor microenvironment.

Implications:

  • The identification of druggable targets offers a potential avenue for future treatment in case of disease recurrence.
Keywords:
HSP90SPARCinterdigitating dendritic cell sarcomatreatment target

More Related Videos

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

Published on: September 14, 2010

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

Related Experiment Videos

Last Updated: Jun 6, 2026

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

Published on: September 14, 2010

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

  • This approach may guide personalized therapy for rare cancers like IDCS.